Bridgebio Pharma Inc (BBIO)

Nov 15, 2025

(BBIO) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Nov 15, 2025

Nov 15, 2025

What moving averages say about BridgeBio Pharma Inc.Market Growth Report & Fast Gain Stock Tips - newser.com

Nov 15, 2025

Nov 15, 2025

How dovish Fed policy supports BridgeBio Pharma Inc. (2CL) stock2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Why BridgeBio Pharma Inc. (2CL) stock stays resilientWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com

Nov 15, 2025

Nov 13, 2025

What drives BridgeBio Pharma Inc stock priceDividend Aristocrats List & Fast Growing Portfolio Trading - earlytimes.in

Nov 13, 2025

Nov 12, 2025

What indicators show strength in BridgeBio Pharma Inc.2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com

Nov 12, 2025

Nov 12, 2025

How BridgeBio Pharma Inc. stock performs in stagflationWeekly Risk Report & Consistent Income Trade Recommendations - newser.com

Nov 12, 2025

Nov 12, 2025

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Wave Life Sciences (WVE) and BridgeBio Pharma (BBIO) - The Globe and Mail

Nov 12, 2025

Nov 12, 2025

BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Wells Fargo Maintains BridgeBio Pharma (BBIO) Overweight Recommendation - Nasdaq

Nov 11, 2025

Nov 11, 2025

BridgeBio Pharma (BBIO): Wells Fargo Raises Price Target to $84 - GuruFocus

Nov 11, 2025

Nov 10, 2025

BridgeBio Pharma CEO Kumar Neil sells $5m in shares By Investing.com - Investing.com Australia

Nov 10, 2025

Nov 10, 2025

BridgeBio Pharma CEO Kumar Neil sells $5m in shares - Investing.com

Nov 10, 2025

Nov 10, 2025

Bridgebio Pharma Insider Sold Shares Worth $4,983,111, According to a Recent SEC Filing - MarketScreener

Nov 10, 2025

Nov 10, 2025

Pfizer’s Advertising Challenge Against BridgeBio’s Attruby Leverages US FDA Untitled Letter - Citeline News & Insights

Nov 10, 2025

Nov 10, 2025

Sustained drop in all-cause mortality observed with BridgeBio’s acoramidis - The Pharma Letter

Nov 10, 2025

Nov 10, 2025

BridgeBio Pharma Insider Sold Shares Worth $3,888,999, According to a Recent SEC Filing - MarketScreener

Nov 10, 2025

Nov 10, 2025

Can machine learning forecast BridgeBio Pharma Inc. recoveryTrade Risk Assessment & Low Risk High Reward Ideas - newser.com

Nov 10, 2025

Nov 09, 2025

Analyzing BridgeBio Pharma Inc. with risk reward ratio chartsTrade Risk Assessment & AI Powered Market Entry Ideas - newser.com

Nov 09, 2025

Nov 09, 2025

BridgeBio Pharma’s Global Expansion Shockwave: Why Investors Are Buzzing! - Smartkarma

Nov 09, 2025

Nov 09, 2025

BridgeBio (BBIO) Reports Promising Data for Acoramidis in Cardia - GuruFocus

Nov 09, 2025

Nov 09, 2025

BridgeBio presents data from ATTRibute-CM study on acoramidis - TipRanks

Nov 09, 2025

Nov 08, 2025

BridgeBio Pharma Reports Significant All-Cause Mortality Reductions with Acoramidis in Variant ATTR-CM Patients at AHA Scientific Sessions 2025 - Quiver Quantitative

Nov 08, 2025

Nov 08, 2025

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations - GlobeNewswire

Nov 08, 2025

Nov 08, 2025

Using Bollinger Bands to evaluate BridgeBio Pharma Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com

Nov 08, 2025

Nov 08, 2025

JP Morgan Raises Price Target for BBIO, Maintains Overweight Rat - GuruFocus

Nov 08, 2025

Nov 07, 2025

BridgeBio Pharma Director Makes a Multi-Million Dollar Stock Move! - TipRanks

Nov 07, 2025

Nov 07, 2025

BridgeBio Pharma Director Ronald J Daniels Sells Over $3.8 Million in Company Stock - TradingView

Nov 07, 2025

Nov 07, 2025

Long term debt to total equity ratio of BridgeBio Pharma, Inc. – HAM:2CL - TradingView

Nov 07, 2025

Nov 07, 2025

[Form 4] BridgeBio Pharma, Inc. Insider Trading Activity - Stock Titan

Nov 07, 2025

Nov 07, 2025

National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry - The Manila Times

Nov 07, 2025

Nov 07, 2025

Will BridgeBio Pharma Inc. stock pay special dividendsDay Trade & Daily Profit Focused Screening - newser.com

Nov 07, 2025

Nov 07, 2025

BridgeBio Pharma, Inc. (BBIO) Stock Forecasts - Yahoo! Finance Canada

Nov 07, 2025

Nov 06, 2025

CapEx per share of BridgeBio Pharma, Inc. – MIL:1BBIO - TradingView

Nov 06, 2025

Nov 06, 2025

BridgeBio Pharma: A High-Stakes Biotech Investment - AD HOC NEWS

Nov 06, 2025

Nov 06, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ceribell, Inc. (CBLL), American Well (AMWL) and BridgeBio Pharma (BBIO) - The Globe and Mail

Nov 06, 2025

Nov 06, 2025

How BridgeBio Pharma Inc. (2CL) stock reacts to fiscal policiesWeekly Trend Recap & Reliable Price Breakout Signals - newser.com

Nov 06, 2025

Nov 05, 2025

Why retail investors favor BridgeBio Pharma Inc. stockJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com

Nov 05, 2025

Nov 05, 2025

Real time alert setup for BridgeBio Pharma Inc. performance2025 Key Lessons & Free Accurate Trade Setup Notifications - newser.com

Nov 05, 2025

Nov 05, 2025

Is BridgeBio Pharma Inc. stock a buy in volatile markets2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - fcp.pa.gov.br

Nov 05, 2025

Nov 05, 2025

BridgeBio Pharma Inc (BBIO) Stock Price, Trades & News - GuruFocus

Nov 05, 2025

Nov 05, 2025

13,856 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Bryce Point Capital LLC - MarketBeat

Nov 05, 2025